World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
51672
World Ranking
8140
National Ranking
251

Overview

Laure Gossec is affiliated with Sorbonne University in France. Their research primarily focuses on the field of Medicine with particular specialization in Rheumatology, Immunology, and Hematology. The breadth of their work touches on both clinical and therapeutic aspects of autoimmune and inflammatory disorders.

The scientist's publication record includes significant work in several major scientific venues. Frequent publication venues include:

  • Annals of the Rheumatic Diseases
  • Revue du Rhumatisme
  • Lara D. Veeken
  • RMD Open
  • Joint Bone Spine

Their research topics cover various areas within rheumatology and related health conditions. Main topics addressed comprise:

  • Spondyloarthritis Studies and Treatments
  • Psoriasis: Treatment and Pathogenesis
  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune and Inflammatory Disorders Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • COVID-19 Clinical Research Studies

Frequent co-authors collaborating with Laure Gossec include:

  • Laura C. Coates
  • Anna Moltó
  • Pedro Machado
  • Philip J. Mease
  • Bruno Fautrel

Selected recent publications highlight the scope and impact of their research. These include:

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update (2020, Annals of the Rheumatic Diseases)
  • Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry (2020, Annals of the Rheumatic Diseases)
  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update (2020, Annals of the Rheumatic Diseases)
  • Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry (2021, Annals of the Rheumatic Diseases)
  • EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 (2020, Annals of the Rheumatic Diseases)

Their work contributes to developing clinical guidelines and recommendations, particularly in the context of rheumatoid arthritis, psoriatic arthritis, and rheumatic disease management during the COVID-19 pandemic. Research outputs also include analyses related to hospitalization and mortality risk in rheumatic patients affected by COVID-19.

Best Publications

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados

  • Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.

    Milena Gianfrancesco;Kimme L Hyrich;Sarah Al-Adely;Loreto Carmona

  • European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.

    L Gossec;J S Smolen;S Ramiro;M de Wit

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

    Laure Gossec;Xenofon Baraliakos;Andreas Kerschbaumer;Maarten de Wit

  • Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

    Maarten Boers;John R. Kirwan;George Wells;Dorcas Beaton

  • Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

    Sofia Ramiro;Cécile Gaujoux-Viala;Jackie L Nam;Jackie L Nam;Josef S Smolen

  • Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

    Josef S Smolen;Monika Schöls;Jürgen Braun;Maxime Dougados

  • Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review

    Jérôme Avouac;Laure Gossec;Maxime Dougados

  • Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.

    Anja Strangfeld;Martin Schäfer;Milena A Gianfrancesco;Saskia Lawson-Tovey

  • Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

    Josef S. Smolen;Jürgen Braun;Maxime Dougados;Paul Emery

  • Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials

    Carine Salliot;Maxime Dougados;Laure Gossec

  • European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

    L Gossec;J S Smolen;C Gaujoux-Viala;Z Ash

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    J. S. Smolen;R. Landewé;F. C. Breedveld;M. Dougados

  • Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

    Cécile Gaujoux-Viala;Cécile Gaujoux-Viala;Josef S Smolen;Robert Landewé;Maxime Dougados

  • A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative

    Laure Gossec;Maarten de Wit;Uta Kiltz;Juergen Braun

  • Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review

    Nadine Zeboulon;Maxime Dougados;Laure Gossec

  • Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis

    Jackie L Nam;Sofia Ramiro;Cecile Gaujoux-Viala;Kaoru Takase;Kaoru Takase

  • EULAR recommendations for patient education for people with inflammatory arthritis

    Heidi A. Zangi;Mwidimi Ndosi;Jo Adams;Lena Andersen

  • Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis.

    Sabrina Dadoun;Nadine Zeboulon-Ktorza;Christophe Combescure;Muriel Elhai

Frequent Co-Authors

Maxime Dougados
Maxime Dougados Hôpital Cochin
Bruno Fautrel
Bruno Fautrel Université Paris Cité
Alain Saraux
Alain Saraux University of Western Brittany
Josef S. Smolen
Josef S. Smolen Medical University of Vienna
Tore K. Kvien
Tore K. Kvien University of Oslo
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Robert Landewé
Robert Landewé University of Amsterdam
Francis Berenbaum
Francis Berenbaum Université Paris Cité
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center
Bernard Combe
Bernard Combe University of Montpellier

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine extends beyond traditional MD programs. Today, a wide range of online degrees offer flexible entry points into the healthcare field and support career growth. Nurses interested in mental health roles can consider fast track mental health nursing programs, which allow for quicker progression into specialized nurse practitioner positions.

For those aiming to lead in medical administration, pursuing one of the best online mha programs can open doors to hospital management or policy-making. Cost is often a barrier, but there are options among the cheapest mha online programs that deliver quality education without a high price tag.

Finally, nurses seeking advanced practice roles might look into msn to dnp programs online, which support progression to the highest levels of clinical nursing and leadership. Researching these pathways can help students find the most affordable, flexible, and relevant program to meet their career goals in the dynamic healthcare sector.

Best Scientists Citing Laure Gossec

Trending Scientists

Recently Published Articles